SCHEMBL10694530

SCHEMBL10694530

O=C(Cl)C(c1ccc(Cl)cc1)C1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 4/20 0.49
▸ SLC6A2 P23975 2/20 0.47
▸ SLC6A4 P31645 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ EPHX1 P07099 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HTR1E P28566 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ S1PR3 Q99500 1/20 0.44
▸ CHRM3 P20309 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9644016 0.91 FFAR2 (0.49) SLC6A3SLC6A2SLC6A4SMN1; SMN2HPGD
SCHEMBL1565904 0.86 MEN1 (0.47) SLC6A3SLC6A2SLC6A4MAPTMEN1
SCHEMBL10695328 0.84 NPC1 (0.46) SLC6A3NPC1EPHX1RAB9ASMN1; SMN2
SCHEMBL5736102 0.84 SLC6A3 (0.52) SLC6A3SLC6A2SLC6A4ALDH1A1SMN1; SMN2
SCHEMBL9780781 0.84 HTR1E (0.61) SLC6A3SLC6A2MAPTMEN1LMNA
SCHEMBL17847165 0.82 POLB (0.46) SLC6A3POLBNPC1EPHX1RAB9A
SCHEMBL9966559 0.82 POLB (0.46) SLC6A3POLBNPC1EPHX1RAB9A
SCHEMBL2644996 0.81 HTR1E (0.63) SLC6A3SLC6A2MAPTMEN1LMNA
SCHEMBL8875745 0.81 HTR1E (0.63) SLC6A3SLC6A2MAPTMEN1LMNA
SCHEMBL9942263 0.81 SLC6A3 (0.44) SLC6A3SLC6A2SLC6A4ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3116862-A1 PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2017-01-18 — — EP disclosed
WO-2015138220-A1 PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-09-17 — — WO disclosed
EP-0272580-A2 Liquidcrystalline cyclohexylbenzene derivatives their manufacturing and novel nematic admixtures containing same Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego (PL) 1988-06-29 — — EP disclosed
Send feedback